Display options
Cite
Leggett LE, Soril LJ, Coward S, et al. Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Adult and Youth Populations: A Systematic Literature Review and Meta-Analysis. Prim Care Companion CNS Disord. 2015;17(6)doi: 10.4088/PCC.15r01807.
Leggett, L. E., Soril, L. J., Coward, S., Lorenzetti, D. L., MacKean, G., & Clement, F. M. (2015). Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Adult and Youth Populations: A Systematic Literature Review and Meta-Analysis. The primary care companion for CNS disorders, 17(6), . https://doi.org/10.4088/PCC.15r01807
Leggett, Laura E, et al. "Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Adult and Youth Populations: A Systematic Literature Review and Meta-Analysis." The primary care companion for CNS disorders vol. 17,6 (2015). doi: https://doi.org/10.4088/PCC.15r01807
Leggett LE, Soril LJ, Coward S, Lorenzetti DL, MacKean G, Clement FM. Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Adult and Youth Populations: A Systematic Literature Review and Meta-Analysis. Prim Care Companion CNS Disord. 2015 Nov 05;17(6). doi: 10.4088/PCC.15r01807. eCollection 2015. PMID: 27057417; PMCID: PMC4805418.
Copy Download .nbib Format: NLM
Share it on

Prim Care Companion CNS Disord. 2015 Nov 05;17(6). doi: 10.4088/PCC.15r01807. eCollection 2015.

Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Adult and Youth Populations: A Systematic Literature Review and Meta-Analysis.

The primary care companion for CNS disorders

Laura E Leggett, Lesley J J Soril, Stephanie Coward, Diane L Lorenzetti, Gail MacKean, Fiona M Clement

Affiliations

  1. Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; Institute for Public Health, University of Calgary, Calgary, Alberta, Canada.
  2. Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; Institute of Health Economics, Edmonton, Alberta, Canada.

PMID: 27057417 PMCID: PMC4805418 DOI: 10.4088/PCC.15r01807

Abstract

BACKGROUND: Between 30% and 60% of individuals with major depressive disorder will have treatment-resistant depression (TRD): depression that does not subside with pharmaceutical treatment. Repetitive transcranial magnetic stimulation (rTMS) is an emerging treatment for TRD.

OBJECTIVE: To establish the efficacy and optimal protocol for rTMS among adults and youth with TRD.

DATA SOURCES: Two systematic reviews were conducted: one to determine the efficacy of rTMS for adults with TRD and another to determine the effectiveness of rTMS for youth with TRD. For adults, MEDLINE, Cochrane Central Register of Controlled Trials, PubMed, EMBASE, PsycINFO, Cochrane Database of Systematic Reviews, and Health Technology Assessment Database were searched from inception until January 10, 2014 with no language restrictions. Terms aimed at capturing the target diagnosis, such as depression and depressive disorder, were combined with terms describing the technology, such as transcranial magnetic stimulation and rTMS. Results were limited to studies involving human participants and designed as a randomized controlled trial. For youth, the search was altered to include youth only (aged 13-25 years) and all study designs. When possible, meta-analysis of response and remission rates was conducted.

STUDY SELECTION: Seventy-three articles were included in this review: 70 on adult and 3 on youth populations.

RESULTS: Meta-analysis comparing rTMS and sham in adults found statistically significant results favoring rTMS for response (RR: 2.35 [95% CI, 1.70-3.25]) and remission (RR: 2.24 [95% CI, 1.53-3.27]). No statistically significant differences were found when comparing high- and low-frequency, unilateral and bilateral, low- and high-intensity rTMS or rTMS and electroconvulsive therapy (ECT). While meta-analysis of results from the youth literature was not possible, the limited evidence base suggests that rTMS may be effective for treating TRD in youth.

CONCLUSIONS: The evidence available on the use of rTMS for adults with TRD indicates that rTMS is approximately twice as effective as a sham procedure, although the optimal rTMS protocol remains unclear. Evidence also indicates that rTMS is as effective as ECT and appears promising as a treatment for youth with TRD; however, the evidence base is underdeveloped.

References

  1. Am J Psychiatry. 1999 Jun;156(6):946-8 - PubMed
  2. Am J Psychiatry. 2006 Jan;163(1):88-94 - PubMed
  3. Int J Neuropsychopharmacol. 2013 Oct;16(9):1975-84 - PubMed
  4. Psychol Med. 2013 Nov;43(11):2245-54 - PubMed
  5. Psychiatry Res. 1999 Nov 29;88(3):163-71 - PubMed
  6. J Clin Psychiatry. 2006 Dec;67(12):1870-6 - PubMed
  7. J Affect Disord. 2012 Feb;136(3):249-57 - PubMed
  8. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Oct 1;34(7):1189-95 - PubMed
  9. Int J Neuropsychopharmacol. 2006 Dec;9(6):667-76 - PubMed
  10. Br J Psychiatry. 2004 Jun;184:541-2 - PubMed
  11. Am J Psychiatry. 2011 May;168(5):502-10 - PubMed
  12. Psychiatry Res. 2005 Nov 15;137(1-2):1-10 - PubMed
  13. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Dec 3;39(2):364-70 - PubMed
  14. Arch Gen Psychiatry. 2008 Mar;65(3):268-76 - PubMed
  15. Biol Psychiatry. 2003 Apr 15;53(8):649-59 - PubMed
  16. J Epidemiol Community Health. 1998 Jun;52(6):377-84 - PubMed
  17. Psychol Med. 2012 May;42(5):981-8 - PubMed
  18. Biol Psychiatry. 2000 Feb 15;47(4):332-7 - PubMed
  19. Clin Neurophysiol. 2005 May;116(5):1062-71 - PubMed
  20. Neuropsychopharmacology. 2002 Oct;27(4):638-45 - PubMed
  21. J Affect Disord. 2012 Jul;139(2):193-8 - PubMed
  22. J ECT. 2012 Jun;28(2):84-6 - PubMed
  23. Aust N Z J Psychiatry. 2006 Sep;40(9):759-63 - PubMed
  24. Health Technol Assess. 2007 Jul;11(24):1-54 - PubMed
  25. Neuropsychiatr Dis Treat. 2006 Mar;2(1):85-94 - PubMed
  26. Int J Neuropsychopharmacol. 2006 Dec;9(6):655-66 - PubMed
  27. Psychol Med. 2003 Jan;33(1):33-40 - PubMed
  28. Depress Anxiety. 2004;19(1):59-62 - PubMed
  29. Neuropsychobiology. 2010;62(2):91-7 - PubMed
  30. Front Psychiatry. 2012 Mar 07;3:13 - PubMed
  31. J Clin Psychopharmacol. 2008 Feb;28(1):52-8 - PubMed
  32. J Affect Disord. 2009 Nov;118(1-3):94-100 - PubMed
  33. Nord J Psychiatry. 2006;60(4):282-5 - PubMed
  34. J ECT. 2011 Dec;27(4):310-4 - PubMed
  35. Depress Anxiety. 2000;12(3):118-23 - PubMed
  36. Neuropsychopharmacology. 2013 Mar;38(4):543-51 - PubMed
  37. Biol Psychiatry. 2002 Apr 15;51(8):659-67 - PubMed
  38. Neuropsychopharmacology. 2009 Apr;34(5):1255-62 - PubMed
  39. Pharmacopsychiatry. 2008 Mar;41(2):41-7 - PubMed
  40. Int J Neuropsychopharmacol. 2000 Jun;3(2):129-134 - PubMed
  41. J Affect Disord. 2009 Jun;115(3):386-94 - PubMed
  42. Psychol Med. 2011 Jun;41(6):1187-96 - PubMed
  43. Neuroscience. 2010 May 5;167(2):323-8 - PubMed
  44. Lancet. 1996 Jul 27;348(9022):233-7 - PubMed
  45. Arch Gen Psychiatry. 2003 Oct;60(10):1002-8 - PubMed
  46. Ann Clin Psychiatry. 2005 Jul-Sep;17(3):153-9 - PubMed
  47. Brain Stimul. 2009 Oct;2(4):188-200 - PubMed
  48. Neurology. 2002 Apr 23;58(8):1288-90 - PubMed
  49. Brain Stimul. 2010 Jul;3(3):140-52 - PubMed
  50. J Affect Disord. 2009 Oct;117 Suppl 1:S44-53 - PubMed
  51. J Affect Disord. 2001 May;64(2-3):271-5 - PubMed
  52. Biol Psychiatry. 2003 Feb 15;53(4):324-31 - PubMed
  53. Psychiatry Res. 2007 Mar 30;150(2):181-6 - PubMed
  54. J ECT. 2012 Jun;28(2):104-7 - PubMed
  55. J ECT. 2008 Jun;24(2):156-9 - PubMed
  56. J Nerv Ment Dis. 1999 Feb;187(2):114-7 - PubMed
  57. Psychiatry Res. 2010 Aug 15;178(3):467-74 - PubMed
  58. Biol Psychiatry. 2007 Dec 1;62(11):1208-16 - PubMed
  59. Depress Anxiety. 2004;19(1):24-30 - PubMed
  60. Australas Psychiatry. 2004 Sep;12(3):234-8 - PubMed
  61. Int J Neuropsychopharmacol. 2010 Feb;13(1):45-59 - PubMed
  62. J Clin Psychiatry. 2013 Feb;74(2):e122-9 - PubMed
  63. Neuropsychiatr Dis Treat. 2013;9:397-401 - PubMed
  64. Arch Gen Psychiatry. 2010 May;67(5):507-16 - PubMed
  65. Int Psychogeriatr. 2001 Jun;13(2):225-31 - PubMed
  66. Brain Stimul. 2014 Jan-Feb;7(1):36-41 - PubMed
  67. J Affect Disord. 2013 Jan 10;144(1-2):153-9 - PubMed
  68. Psychol Med. 2007 Mar;37(3):341-9 - PubMed
  69. J Affect Disord. 2013 Nov;151(2):625-31 - PubMed
  70. J Clin Psychiatry. 2014 May;75(5):477-89; quiz 489 - PubMed
  71. J Child Adolesc Psychopharmacol. 2012 Feb;22(1):56-64 - PubMed
  72. Neuropsychopharmacology. 2009 Jan;34(2):522-34 - PubMed
  73. Psychol Med. 2014 Jan;44(2):225-39 - PubMed
  74. Psychiatry Res. 2006 Jan 30;146(1):53-7 - PubMed
  75. Biol Psychiatry. 2006 Jan 15;59(2):187-94 - PubMed
  76. Psychiatry Res. 2002 Dec 30;113(3):245-54 - PubMed
  77. Psychiatry Res. 2004 Apr 30;126(2):123-33 - PubMed
  78. J Neuropsychiatry Clin Neurosci. 2007 Spring;19(2):179-86 - PubMed
  79. Depress Anxiety. 2009;26(3):229-34 - PubMed
  80. World J Biol Psychiatry. 2012 Sep;13(6):423-35 - PubMed
  81. Hum Psychopharmacol. 2002 Oct;17(7):353-6 - PubMed
  82. Brain Stimul. 2013 Jan;6(1):54-61 - PubMed
  83. J Clin Psychopharmacol. 2007 Oct;27(5):488-92 - PubMed
  84. J Clin Psychiatry. 2005 Jul;66(7):930-7 - PubMed
  85. Biol Psychiatry. 2004 Feb 15;55(4):398-405 - PubMed

Publication Types